Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jul 30, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new method called Coplanar Template Assisted Seed Implantation to see how accurately it can help treat abdominal and pelvic cancers. This method uses a special guide or template that helps doctors place tiny radioactive seeds precisely where they need to go in the body, which might improve treatment outcomes. While this technique has shown promise for other types of cancer, this trial aims to gather more information specifically about its safety and accuracy for abdominal and pelvic cancers.

To participate in this trial, individuals must be between 18 and 85 years old and have one or more solid tumors in the abdomen or pelvis. It's important that they have good general health and can tolerate the procedure. Participants should not be taking certain medications that affect blood clotting, and they need to provide informed consent to join the study. If eligible, participants can expect to undergo the seed implantation procedure guided by this new template method, with careful monitoring to ensure their safety throughout the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Ages 18 to 85
• • 2. Single or multiple abdominal or pelvic tumors (solid, partially solid)
• • 3. Without taking drugs affecting coagulation and/or platelet aggregation are used; If used, the drug has been discontinued for a sufficient period of time (e.g. 1 week)
• • 4. KPS\>60 points with expected survival \>3 months, no serious or uncontrolled underlying diseases, clinical evaluation patients can tolerate puncture
• • 5. Planned seed implantation with applicable puncture path
• • 6. With informed consent.
• Exclusion Criteria:
• • 1. Poor organ function (e.g. Liver decompensation)
• • 2. The lesion close to blood vessels and intestine, or there is portal vein hypertension and superior vena cava compression, etc., which are expected to have high risks of puncture bleeding and intestinal injury
• • 3. Poor compliance, unable to complete coordination
• • 4. Paticipant who is considered inappropriate or unwilling to participate in this clinical trial for other reasons.